ClinicalTrials.Veeva

Menu

A Comparison of Epidural Block With Adding Sciatic Block to Continuous Femoral Block in Total Knee Arthroplasty

Y

Yeungnam University College of Medicine

Status

Unknown

Conditions

Postoperative Pain

Treatments

Device: epidural infusion
Device: femoral sciatic

Study type

Interventional

Funder types

Other

Identifiers

NCT02235506
apsj0901

Details and patient eligibility

About

The investigators compared continuous epidural infusion with combined continuous femoral and single-shot sciatic nerve blocks. The primary outcome was the incidence of side effects, and secondary outcomes were pain relief, motor blockade,morphine consumption, and rehabilitation indices.

Full description

The parcicipants were randomly assingned to epidural infusion group and femoral sciatic block. In epidural infusion group, a lumbar epidural catheter was placed at the L3-4 level using loss-ofresistance procedure. ropivacaine 0.2% and fentayl 2mcg/ml were infused at a rate of 5ml/hr from the end of operation. In femoral sciatic group, the femoral and sciatic nerve are located using ultrasound and 0.2% ropivacain is injected. A catheter is inserted to femoral nerve. From the end of operation, 0.2% ropivacaine was infused through the femoral catheter at a rate of 5ml/hr. The incidence of side effects is measured.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists Physical Status Classification I-II
  • total knee arthroplasty
  • 18-90 years

Exclusion criteria

  • allergic to the local anesthetics
  • cognitive impairment such as dementia
  • coagulopathy
  • motor and sensory impairment
  • patient refusal
  • BMI >39

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

epidural infusion
Experimental group
Description:
In epidural infusion group, a lumbar epidural catheter was placed at the L3-4 level using loss-ofresistance procedure. ropivacaine 0.2% and fentayl 2mcg/ml were infused at a rate of 5ml/hr from the end of operation,
Treatment:
Device: epidural infusion
Device: epidural infusion
femoral sciatic
Experimental group
Description:
In femoral sciatic group, the femoral and sciatic nerve are located using ultrasound and 0.2% ropivacain is injected. A catheter is inserted to femoral nerve. From the end of operation, 0.2% ropivacaine was infused through the femoral catheter at a rate of 5ml/hr.
Treatment:
Device: femoral sciatic
Device: femoral sciatic

Trial contacts and locations

1

Loading...

Central trial contact

Sangjin Park, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems